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A 37-year-old woman became
disoriented, hallucinating and agi-
tated after complaining of headache
2 weeks earlier. She was admitted to
a psychiatric clinic, where she
developed low-grade fever, gait dis-
turbances and orofacial dyskinesias.
Thus, she was referred to our hospital
for further evaluation. Routine labo-
ratory analyses and brain imaging
showed no abnormalities. Lumbar
puncture revealed mononuclear pleo-
cytosis, but extensive microbiology
testing showed no evidence of
microorganisms. Autoantibodies
against the CNS antigens Hu, Ri, Yo,
amphiphysin, CV2, Ta/Ma2, Ma and
recoverin were undetectable. Ten
days after admission, the patient
developed generalized seizures.
Treatment with phenytoin and high-
dose midazolam was initiated, and the
patient was transferred to the ICU for
mechanical ventilation. Although
repeated lumbar punctures docu-
mented a continuous drop in CSF cell
count from 44 to 2 cells/ll within a
month, the patient remained in a
mostly non-convulsive intermittent
status epilepticus refractory to treat-
ment with various antiepileptic drugs
for nearly 2 months. She further
developed severe hyperthermia,
hypersalivation, tachycardia and epi-
sodes of bradycardia. Incidentally, a
computed tomography of the abdo-
men revealed a mature ovarian
teratoma (Fig. 1). Treatment with
high-dose prednisolone and intrave-
nous immunoglobulines was started.
After cessation of seizures, the patient
underwent laparoscopic teratoma
removal. Histologic examination
revealed the presence of neuronal
tissue within the teratoma, and high
titers of antibodies against NMDA-
receptors were detected in the
patient’s CSF (Fig. 2). Midazolam
was tapered after surgery, and the
patient regained consciousness. One
year later, she was able to resume
work as a postman without any
residual deficits.
The possible association of
encephalitis with teratoma has been
noted for a while (reviewed by
Gultekin [1]), but only recent studies
have identified an association of this
syndrome with antibodies to the
NMDA receptor [2, 3]. These
antibodies lead to reversible down-
regulation of hippocampal NMDA
receptors through a non-cytotoxic
mechanism [3]. They probably arise
by autoimmunisation due to the
expression of NMDA receptors in
neuronal tissue within the teratoma
[2] and might initially pass the blood-
brain barrier after its disruption by a
precedent hit such as viral meningitis,
as suggested by the CSF pleocytosis
present in most patients. During the
course of the disease, however, most
patients exhibit local production of
antibodies within the CNS as indi-
cated by the higher antibody titers in
CSF as compared to serum [3]. Of
interest, nearly half of patients suf-
fering from encephalitis associated
with anti-NMDA-receptor antibodies
have no detectable teratoma [3],
suggesting alternative mechanisms of
autoimmunization. The disease
predominantly affects young women
and is characterized by prominent
psychiatric symptoms, dyskinesias,
seizures, autonomic instability and
central hypoventilation. Many
patients display no abnormalities on
neuroimaging studies, consistent with
the antibody-mediated non-inflam-
matory nature of the disease [4].
Symptoms are mostly reversible upon
immunotherapy and tumor removal,
and patients without a detectable ter-
atoma show more protracted
symptoms and relapses, although they
often recover [1]. Anti-NMDA-
receptor encephalitis is probably
more common than previously
Fig. 1 Abdominal CT disclosed a cystic mass in the right pelvis containing a tooth (arrow)
suggestive of mature ovarian teratoma
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estimated and should be considered in
any case of unexplained encephalitis,
especially in young women.
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Fig. 2 Cultured rat hippocampal neurons were incubated with the patient’s CSF revealing
binding of autoantibodies to NMDA receptors (green dots) visualized by adding a
fluorescence-labeled secondary antibody to human immunoglobulin
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